The First Clinical Medical College, Gannan Medical University, Ganzhou, 341000, Jiangxi, China.
Department of Oncology, The First Affiliated Hospital of Gannan Medical University, 128 Jinling Road, Ganzhou, 341000, Jiangxi, China.
J Transl Med. 2024 Sep 27;22(1):858. doi: 10.1186/s12967-024-05693-8.
LINC01089 is a prime example of a long non-coding RNA that plays a pivotal role in the progression of human cancers. The gene encoding this lncRNA is located on 12q24.31. LINC01089 has been demonstrated to exert tumor-suppressive effects in various cancers, including colorectal cancer, gastric cancer, lung cancer, ovarian cancer, cervical cancer, papillary thyroid carcinoma, breast cancer, and osteosarcoma. However, its role in hepatocellular carcinoma shows significant discrepancies across different studies. In this review, we systematically explore the functions of LINC01089 in human cancers through bioinformatics analysis, clinical studies, animal models, and fundamental experimental research. Furthermore, we delve into the biological mechanisms and functions of LINC01089, and discuss its potential as a future biomarker and therapeutic target in detail.
LINC01089 是长链非编码 RNA 的一个典型代表,在人类癌症的进展中起着关键作用。编码这种 lncRNA 的基因位于 12q24.31。已经证明 LINC01089 在多种癌症中发挥肿瘤抑制作用,包括结直肠癌、胃癌、肺癌、卵巢癌、宫颈癌、甲状腺乳头状癌、乳腺癌和骨肉瘤。然而,其在肝细胞癌中的作用在不同的研究中存在显著差异。在这篇综述中,我们通过生物信息学分析、临床研究、动物模型和基础实验研究系统地探讨了 LINC01089 在人类癌症中的功能。此外,我们深入探讨了 LINC01089 的生物学机制和功能,并详细讨论了其作为未来生物标志物和治疗靶点的潜力。